How many insider trades does FilingIQ track for DCTH?

FilingIQ tracks 170 Form 4 insider transactions for DCTH (DELCATH SYSTEMS, INC.), covering filings from Jun 10, 2015 onwards. 19 of those were filed in the last 90 days.

Are DCTH insiders net buyers or net sellers?

Across the full Form 4 history for DCTH, 85 transactions (50%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does DCTH insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is DCTH in?

DELCATH SYSTEMS, INC. (DCTH) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $345.54M.

DCTH insider trading

NasdaqCM Healthcare

DELCATH SYSTEMS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

170

Last 90 days

Buys / sells

50% / 0%

Market cap

$345.54M

About DELCATH SYSTEMS, INC.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1987 and is headquartered in New York, New York.

Company website: www.delcath.com

DCTH insider activity at a glance

FilingIQ has scored 170 insider transactions for DCTH since Jun 10, 2015. The most recent filing in our index is dated May 13, 2026.

Across the full history, 85 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on DCTH insider trades is 53.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live DCTH trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for DCTH?: FilingIQ tracks 170 Form 4 insider transactions for DCTH (DELCATH SYSTEMS, INC.), covering filings from Jun 10, 2015 onwards. 19 of those were filed in the last 90 days.
Are DCTH insiders net buyers or net sellers?: Across the full Form 4 history for DCTH, 85 transactions (50%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does DCTH insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is DCTH in?: DELCATH SYSTEMS, INC. (DCTH) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $345.54M.

Methodology & sources

Every DCTH insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.